Show simple item record

dc.creatorSweet, Melissaen
dc.date.accessioned2016-01-09T00:10:09Zen
dc.date.available2016-01-09T00:10:09Zen
dc.date.created2003-05-03en
dc.date.issued2003-05-03en
dc.identifierdoi:10.1136/bmj.326.7396.952/aen
dc.identifier.bibliographicCitationBMJ: British Medical Journal 2003 May 3; 326(7396): 952en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=GlaxoSmithKline+takes+legal+action+to+block+new+controls+on+its+smoking+cessation+drug&title=BMJ:+British+Medical+Journal+&volume=326&issue=7396&spage=952&date=2003-05&au=Sweet,+Melissaen
dc.identifier.urihttp://dx.doi.org/10.1136/bmj.326.7396.952/aen
dc.identifier.urihttp://hdl.handle.net/10822/1000561en
dc.formatNews Articleen
dc.languageenen
dc.sourceeweb:259802en
dc.subjectSmokingen
dc.subject.classificationSocial Control of Science and Technologyen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationHealth Care for Substance Abusers / Users of Controlled Substancesen
dc.titleGlaxoSmithKline Takes Legal Action to Block New Controls on Its Smoking Cessation Drugen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2023 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885